Plasma levels of high-mobility group box 1 and soluble receptor for advanced glycation end products in primary antiphospholipid antibody syndrome patients

INTRODUCTION: Many studies have demonstrated elevated circulating levels of high-mobility group box 1 (HMGB1) and decreased circulating levels of soluble receptor for advanced glycation end products (sRAGE) in patients with autoimmune diseases. In the present study, we investigated plasma levels of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Kuo-Tung, Hsieh, Tsu-Yi, Chao, Ya-Hsuan, Lin, Meng-Xian, Chen, Yi-Hsing, Chen, Der-Yuan, Lin, Chi-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448773/
https://www.ncbi.nlm.nih.gov/pubmed/28558055
http://dx.doi.org/10.1371/journal.pone.0178404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448773/
https://www.ncbi.nlm.nih.gov/pubmed/28558055
http://dx.doi.org/10.1371/journal.pone.0178404

Ejemplares similares